These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation. Bai J; Wang YJ; Liu L; Zhao YL J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927 [TBL] [Abstract][Full Text] [Related]
3. Regulation of signaling interactions and receptor endocytosis in growing blood vessels. Pitulescu ME; Adams RH Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636 [TBL] [Abstract][Full Text] [Related]
5. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease. Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793 [TBL] [Abstract][Full Text] [Related]
6. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119 [TBL] [Abstract][Full Text] [Related]
7. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation. Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183 [TBL] [Abstract][Full Text] [Related]
8. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. Nguyen TM; Arthur A; Hayball JD; Gronthos S Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177 [TBL] [Abstract][Full Text] [Related]
9. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333 [TBL] [Abstract][Full Text] [Related]
10. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development. Chennakesava CS; Di Santo S; Ziemiecki A; Schneider H; Andres AC Placenta; 2006; 27(9-10):959-67. PubMed ID: 16343615 [TBL] [Abstract][Full Text] [Related]
13. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705 [TBL] [Abstract][Full Text] [Related]
14. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment. Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666 [TBL] [Abstract][Full Text] [Related]
15. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537 [TBL] [Abstract][Full Text] [Related]
16. The differential expression of EPHB4 and ephrin B2 in cutaneous squamous cell carcinoma according to the grade of tumor differentiation: a clinicopathological study. Oh ST; Yang KJ; Bae JM; Park HJ; Yoo DS; Park YM Int J Dermatol; 2021 Jun; 60(6):736-741. PubMed ID: 33598934 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4. Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822 [TBL] [Abstract][Full Text] [Related]
18. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475 [TBL] [Abstract][Full Text] [Related]
19. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity. Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T Elife; 2020 Sep; 9():. PubMed ID: 32897857 [TBL] [Abstract][Full Text] [Related]
20. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]